| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.93B | +10.6% |
| Cost of Revenue | $2.67B | +7.9% |
| R&D Expense | $1.79B | +6.0% |
| SG&A Expense | $979.1M | +6.5% |
| Operating Income | -$532.2M | +32.4% |
| Pre-tax Income | -$451.1M | +32.9% |
| Income Tax | $9.4M | -63.5% |
| Net Income | -$460.5M | +34.0% |
| EPS (Basic) | -$0.27 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | -1.5% |
| Short-term Investments | $1.91B | -18.0% |
| Accounts Receivable | $1.37B | +1.8% |
| Current Assets | $4.58B | -6.6% |
| Total Assets | $7.68B | -3.3% |
| Current Liabilities | $1.29B | +3.5% |
| Long-term Debt | $3.54B | -2.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $656.2M | +58.7% |
| Capital Expenditures | $219.0M | +12.4% |
| Investing Cash Flow | $173.1M | +124.1% |
| Financing Cash Flow | -$848.1M | -97.9% |
| Free Cash Flow | $437.2M | +99.9% |
| +35.7% |
| EPS (Diluted) | -$0.27 | +35.7% |
| Total Liabilities |
| $5.40B |
| -1.6% |
| Stockholders' Equity | $2.28B | -6.9% |